Phase IV Criteria-Emergency Department
1. Keep in fatal cases.
2. Exclude disposition of admitted to the hospital. (For most states these are not included in the ED dataset)
Tables to Include:
4.0: Table 0
4.1: Table 1.1a-(Maybe) Number of Drug T Codes Listed per Record
4.2: Table 1.1b-The Drug Class of the First Listed Drug T Code
4.3: Table 1.3-Frequency of Intent-(Looks at first listed T Code only, definition has to be relaxed to capture all intents)
4.4: Table 1.4- Presence of Other External Cause of Injury Codes (Need to do for both case definitions principal and any mention)
4.5: Table 1.6-Position of First Mentioned Drug T Code
4.6: Table 1.7-Primary Diagnosis for ED Visits with Any Mention Drug T Code
4.7: Table 1.9b-Frequency of Intent for Any Mention of Drug T Codes
4.8: Table 1.11a-Number Expired in ED with Principal Diagnosis of Drug T Code and
4.9: Table 1.11b-Number of Expired in ED with Any Mention of Drug T Codes
4.10: Table 2.3-Specific Drug Definitions and Investigation of Adverse Effects Intent Codes and Behavioral Health Codes (Do total Ns)
4.11: Table 2.4 (a-c)-Investigation of Potential Changes to PfS/DDPI Indicator Definitions. Excluding discharge codes of deceased/expired. (Total Ns)
4.12: Table 2.5
4.13: Table 3.2- Poly Drug Matrix
2. Exclude disposition of admitted to the hospital. (For most states these are not included in the ED dataset)
Tables to Include:
4.0: Table 0
4.1: Table 1.1a-(Maybe) Number of Drug T Codes Listed per Record
4.2: Table 1.1b-The Drug Class of the First Listed Drug T Code
4.3: Table 1.3-Frequency of Intent-(Looks at first listed T Code only, definition has to be relaxed to capture all intents)
4.4: Table 1.4- Presence of Other External Cause of Injury Codes (Need to do for both case definitions principal and any mention)
4.5: Table 1.6-Position of First Mentioned Drug T Code
4.6: Table 1.7-Primary Diagnosis for ED Visits with Any Mention Drug T Code
4.7: Table 1.9b-Frequency of Intent for Any Mention of Drug T Codes
4.8: Table 1.11a-Number Expired in ED with Principal Diagnosis of Drug T Code and
4.9: Table 1.11b-Number of Expired in ED with Any Mention of Drug T Codes
4.10: Table 2.3-Specific Drug Definitions and Investigation of Adverse Effects Intent Codes and Behavioral Health Codes (Do total Ns)
4.11: Table 2.4 (a-c)-Investigation of Potential Changes to PfS/DDPI Indicator Definitions. Excluding discharge codes of deceased/expired. (Total Ns)
4.12: Table 2.5
4.13: Table 3.2- Poly Drug Matrix
Comments & Events
Katelyn Hall - CO turned on public link sharing for this document
on